SGTX logo

Sigilon Therapeutics (SGTX) Revenue

Annual Revenue

$12.94 M
+$3.35 M+34.85%

December 31, 2022


Summary


Performance

SGTX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSGTXprofitabilitymetrics:

Quarterly Revenue

$5.90 M
+$1.04 M+21.45%

June 30, 2023


Summary


Performance

SGTX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$17.65 M
+$3.02 M+20.61%

June 30, 2023


Summary


Performance

SGTX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSGTXprofitabilitymetrics:

SGTX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.9%+104.7%+76.8%
3 y3 years-8.6%+202.4%+107.3%
5 y5 years+179.2%+90.5%+469.9%

SGTX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-25.8%at high-66.3%at high-45.6%
5 y5-year-8.6%-25.8%at high-67.0%at high-82.5%
alltimeall time-8.6%-64.2%at high-67.0%at high-82.5%

Sigilon Therapeutics Revenue History

DateAnnualQuarterlyTTM
Jun 2023
-
$5.90 M(+21.4%)
$17.65 M(+20.6%)
Mar 2023
-
$4.86 M(+83.7%)
$14.64 M(+13.1%)
Dec 2022
$12.94 M(+34.8%)
$2.64 M(-37.8%)
$12.94 M(+5.3%)
Sep 2022
-
$4.25 M(+47.5%)
$12.29 M(+23.1%)
Jun 2022
-
$2.88 M(-8.9%)
$9.98 M(+1.8%)
Mar 2022
-
$3.17 M(+59.0%)
$9.81 M(+2.2%)
Dec 2021
$9.60 M
$1.99 M(+2.2%)
$9.60 M(-15.5%)
Sep 2021
-
$1.95 M(-28.0%)
$11.37 M(-16.6%)
DateAnnualQuarterlyTTM
Jun 2021
-
$2.70 M(-8.6%)
$13.62 M(+5.9%)
Mar 2021
-
$2.96 M(-21.2%)
$12.87 M(-3.8%)
Dec 2020
$13.37 M(-5.5%)
$3.76 M(-10.6%)
$13.37 M(+5.2%)
Sep 2020
-
$4.20 M(+115.3%)
$12.72 M(+49.3%)
Jun 2020
-
$1.95 M(-43.7%)
$8.52 M(+29.7%)
Mar 2020
-
$3.47 M(+11.9%)
$6.56 M(+111.9%)
Dec 2019
$14.15 M(+205.3%)
$3.10 M
$3.10 M
Dec 2018
$4.64 M
-
-

FAQ

  • What is Sigilon Therapeutics annual revenue?
  • What is the all time high annual revenue for Sigilon Therapeutics?
  • What is Sigilon Therapeutics annual revenue year-on-year change?
  • What is Sigilon Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for Sigilon Therapeutics?
  • What is Sigilon Therapeutics quarterly revenue year-on-year change?
  • What is Sigilon Therapeutics TTM revenue?
  • What is the all time high TTM revenue for Sigilon Therapeutics?
  • What is Sigilon Therapeutics TTM revenue year-on-year change?

What is Sigilon Therapeutics annual revenue?

The current annual revenue of SGTX is $12.94 M

What is the all time high annual revenue for Sigilon Therapeutics?

Sigilon Therapeutics all-time high annual revenue is $14.15 M

What is Sigilon Therapeutics annual revenue year-on-year change?

Over the past year, SGTX annual revenue has changed by +$3.35 M (+34.85%)

What is Sigilon Therapeutics quarterly revenue?

The current quarterly revenue of SGTX is $5.90 M

What is the all time high quarterly revenue for Sigilon Therapeutics?

Sigilon Therapeutics all-time high quarterly revenue is $5.90 M

What is Sigilon Therapeutics quarterly revenue year-on-year change?

Over the past year, SGTX quarterly revenue has changed by +$3.02 M (+104.65%)

What is Sigilon Therapeutics TTM revenue?

The current TTM revenue of SGTX is $17.65 M

What is the all time high TTM revenue for Sigilon Therapeutics?

Sigilon Therapeutics all-time high TTM revenue is $17.65 M

What is Sigilon Therapeutics TTM revenue year-on-year change?

Over the past year, SGTX TTM revenue has changed by +$7.67 M (+76.81%)